InvestorsHub Logo
Followers 19
Posts 1039
Boards Moderated 0
Alias Born 04/18/2018

Re: None

Sunday, 11/22/2020 10:43:51 AM

Sunday, November 22, 2020 10:43:51 AM

Post# of 35961
NOVEMBER 20, 2020

A big win for COLIN HISLOP and Eiger. " Dr. Hislop was the company's senior medical adviser to the Progeria program and was instrumental to Eiger's first NDA submission of Lonafarnib for the treatment of progeria"

The Progeria Research Foundation and Eiger BioPharmaceuticals Celebrate Historic Milestone with FDA Approval of Zokinvy™ (lonafarnib) for the Treatment of Progeria and Processing-Deficient Progeroid Laminopathies

Colin keeps on getting it done!! NOW HE'S IN COTROL OF ALL IP OF NSPX
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RBSH News